Skip to main content
. Author manuscript; available in PMC: 2024 Jun 30.
Published in final edited form as: Exp Dermatol. 2015 Mar;24(3):187–193. doi: 10.1111/exd.12604

Table 2.

Significantly deregulated miRNAs in psoriatic plaque dermal inflammatory infiltrates (PPRD) compared with normal psoriatic reticular dermis (PNRD) (LCM)1

MicroRNA FCH P-value FDR Total RF

hsa-miR-155 7.07 0.00 0.00 31 667
hsa-miR-142-3p 5.18 0.00 0.00 156 616
hsa-miR-21-3p 5.08 0.00 0.00 6316
hsa-miR-142-5p 5.07 0.00 0.00 57 553
hsa-miR-150 4.97 0.00 0.00 78 173
hsa-miR-21 3.98 0.00 0.00 4 403 103
hsa-miR-150-3p 3.60 0.00 0.00 1909
hsa-miR-146b 3.37 0.00 0.00 47 639
hsa-miR-361-3p 3.31 0.00 0.00 4190
hsa-miR-363 3.31 0.00 0.00 2600
hsa-miR-223 3.13 0.00 0.00 25 949
hsa-miR-146a 3.08 0.00 0.00 101 191
hsa-miR-143-5p 2.88 0.00 0.00 41 135
hsa-miR-425 2.64 0.00 0.00 8515
hsa-miR-1307 2.39 0.00 0.01 8253
hsa-miR-342 2.24 0.00 0.00 29 477
hsa-miR-20a 2.09 0.00 0.02 20 289
hsa-miR-193b −2.08 0.00 0.02 7040
hsa-miR-99a −2.08 0.00 0.01 124 753
hsa-miR-199a-1-5p −2.16 0.00 0.00 255 334
hsa-miR-199a-2-5p −2.16 0.00 0.00 255 539
hsa-miR-125b-2 −2.32 0.00 0.00 251 720
hsa-miR-125b-1 −2.33 0.00 0.00 253 985
hsa-miR-101-1-5p −2.34 0.00 0.01 2895
hsa-miR-365-2 −2.39 0.01 0.05 1374
hsa-miR-365-1 −2.40 0.01 0.05 1372
hsa-miR-100 −2.43 0.00 0.00 132 066
hsa-miR-125b-2-3p −2.66 0.00 0.00 3189
hsa-miR-139-3p −2.75 0.00 0.00 4287
hsa-miR-149 −2.78 0.00 0.01 1651
hsa-let-7c −2.81 0.00 0.00 169 038
hsa-miR-200a −3.30 0.00 0.01 3486
hsa-miR-141 −3.41 0.00 0.02 9499
hsa-miR-214-3p −3.56 0.00 0.00 7468
hsa-miR-200c −4.40 0.00 0.00 8633
hsa-miR-200b −5.09 0.00 0.00 3639
hsa-miR-205 −8.08 0.00 0.00 30 020

FCH, fold change; FDR, false discovery rate; PNRD, normal psoriatic reticular dermis, PPRD, psoriatic plaque dermal inflammatory infiltrates; RF, read frequencies.

1

The list include deregulated miRNAs in psoriatic plaque dermal inflammatory infiltrates (PPRD) compared with normal psoriatic reticular dermis (PNRD). FCH > 2. FDR < 0.05. MicroRNAs in bold are novel miRNAs that have not previously been identified in psoriatic skin.